Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_Investor_Feed_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825090112713285632.png) Investor Feed [@_Investor_Feed_](/creator/twitter/_Investor_Feed_) on x 6224 followers
Created: 2025-07-28 13:37:30 UTC

Bajaj Healthcare Q2 2025 Results: Revenue at ₹14,883.63L, PAT ₹1,217.37L 📊 | MCap XXXXXXXX Cr

- Revenue from operations: ₹14,883.63L (vs ₹15,447.25L previous quarter)
- Profit before tax (continuing operations): ₹1,452.51L
- Profit after tax (continuing operations): ₹1,217.37L
- Loss after tax (discontinued operations): ₹34.00L
- Total comprehensive income: ₹1,202.08L
- Basic EPS (continuing operations): ₹3.85; (discontinued operations): ₹(0.11)
- Acquired Genrx Pharmaceuticals (in liquidation) for ₹1,085L in April 2025
- Funds raised via preferential issue used for loan repayment (₹15,000L) and corporate purposes (₹225.90L)

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

![](https://pbs.twimg.com/media/Gw8sxLgaYAAdfAc.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1949826552583373271/c:line.svg)

**Related Topics**
[tax bracket](/topic/tax-bracket)
[mcap](/topic/mcap)
[coins healthcare](/topic/coins-healthcare)
[investment](/topic/investment)

[Post Link](https://x.com/_Investor_Feed_/status/1949826552583373271)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Investor_Feed Avatar Investor Feed @Investor_Feed on x 6224 followers Created: 2025-07-28 13:37:30 UTC

Bajaj Healthcare Q2 2025 Results: Revenue at ₹14,883.63L, PAT ₹1,217.37L 📊 | MCap XXXXXXXX Cr

  • Revenue from operations: ₹14,883.63L (vs ₹15,447.25L previous quarter)
  • Profit before tax (continuing operations): ₹1,452.51L
  • Profit after tax (continuing operations): ₹1,217.37L
  • Loss after tax (discontinued operations): ₹34.00L
  • Total comprehensive income: ₹1,202.08L
  • Basic EPS (continuing operations): ₹3.85; (discontinued operations): ₹(0.11)
  • Acquired Genrx Pharmaceuticals (in liquidation) for ₹1,085L in April 2025
  • Funds raised via preferential issue used for loan repayment (₹15,000L) and corporate purposes (₹225.90L)

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

XXX engagements

Engagements Line Chart

Related Topics tax bracket mcap coins healthcare investment

Post Link

post/tweet::1949826552583373271
/post/tweet::1949826552583373271